Moderna, Inc. vs Tripadvisor Inc Common Stock — how do they compare? Moderna, Inc. trades at $60.75 (market cap $24.18B), while Tripadvisor Inc Common Stock trades at $11.04 (market cap $1.28B). The key difference: Moderna, Inc. is far larger — about 18.9× Tripadvisor Inc Common Stock's market cap, and Moderna, Inc. is trading nearer its 52-week high, Tripadvisor Inc Common Stock nearer its low. Which is the better fit depends on your goals.
| MRNA | TRIP | |
|---|---|---|
Market Cap | $24.18B | $1.28B |
Sector | Health | Consumer Cyclical |
52-Week High | $81.80 | $19.14 |
52-Week Low | $22.36 | $9.24 |
Enterprise Value | $20.33B | $1.33B |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →